Smart Immune Announces Research Collaboration with Memorial Sloan Kettering Cancer Center (MSKCC) to Expedite Development of a Next Generation CAR-T Through its Long Lasting, Exhaustion-Free CAR ProTcell™ Platform

Smart Immune SAS, a clinical stage T-cell medicine company utilizing its proprietary ex-vivo biomimetic “thymus-in-a-dish” technology to develop T-cell progenitors (ProTcell™) to reset a rapid, safe and full immune reconstitution, announced today a research collaboration with Memorial Sloan Kettering Cancer Center (MSKCC).